Articles tagged with "Biosimilars"

FDA Approves Cyltezo, an Interchangeable Biosimilar to Humira

October 19, 2021 • By U.S. Food & Drug Administration

Executive Order Targets Prescription Drugs & Health Insurance to Promote Competition

July 19, 2021

Injection Pen May Reduce Injection Fear Among RA Patients Taking Etanercept Biosimilar

May 28, 2021 • By Michele B. Kaufman, PharmD, BCGP

The Race Is On: Clinical Trials Begin for Agents Biosimilar to Denosumab

May 24, 2021 • By Michele B. Kaufman, PharmD, BCGP

UnitedHealthcare Designates Avsola, Inflectra Preferred Infliximab Products

February 8, 2021 • By From the College

Biologics in Rheumatology: Revolution & Perspectives

December 8, 2020 • By Lara C. Pullen, PhD

Biosimilar Prescribing Habits in the VA & Academic Settings

June 29, 2020 • By Arthritis & Rheumatology

U.S. Insurers Often Limit Biosimilar Coverage

May 29, 2020 • By Lisa Rapaport

British Columbia Will Be First Canadian Province to Switch Patients to Biosimilars

May 29, 2019 • By Allison Martell & Allison Lampert

ACR Hill Visits Yield Key Bill Support; Plus Medicare, Biosimilar Wins

May 20, 2019 • By Angus Worthing, MD, FACP, FACR

1
2
3
…
7
Next Page »